Because it is expressed in gastrinoma and bronchial lung cancer, it holds great promise for molecular imaging of NENs when the GLP-1R is negative (Papaefthymiou et al., 2022). The gene discussed is GLP1R; the disease is gastrin-producing neuroendocrine tumor.